Certified by Founder Lodge
Addition Therapeutics
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Addition Therapeutics is on a mission to fulfill the transformative promise of genomic medicine for people impacted by both chronic and rare diseases. Leveraging our breakthrough all-RNA, non
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 18 ,2025 | Unknown | $100,000,000 |
Osage University Partners (OUP)
Abingworth
SR One Capital Management
BEVC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
